Abstract
Psoriasis is a chronic inflammatory disease believed to be correlated with numerous cardiovascular risk factors including increased blood pressure, elevated blood cholesterol level, diabetes, inactivity, high body mass index (obesity) and dyslipidaemia. The present meta-analysis intends to assess the association between psoriasis and cardiovascular risk factors. Three hundred and fifty articles were primarily screened using NCBI MEDLINE/PubMed and Cochrane library from its inception until June 30, 2018. Of these, 26 observational studies depending upon the inclusion and exclusion criteria were included in the study with 17,672 psoriasis patients and 66,407 non-psoriasis subjects. The psoriasis patients were found to be at significantly increased risk of systolic blood pressure (SBP) [ORs 2.31 (95% CI 1.12, 4.74)], diastolic blood pressure (DBP) [ORs 2.31 (95% CI 1.58, 3.38)], abdominal obesity [ORs 1.90 (95% CI 1.45, 2.50)] and triglycerides [ORs 1.80 (95% CI 1.29, 2.51)] as compared to non-psoriasis subjects. The subgroup analyses of studies based on the continents revealed that psoriasis patients from Middle East are prone to higher risk factors of CVD including increased levels of triglyceride, cholesterol, DBP, SBP, fasting blood sugar, body mass index and decreased HDL levels, whereas psoriasis patients from European population reported increased LDL-C and waist circumference. The present study supports a significant association between psoriasis and incidence of major adverse cardiovascular events. Contrary to the previous literature, our finding suggests that hypertension is a highly associative condition in psoriasis. The findings of this study could be validated amongst well-defined cohorts of patients with psoriasis individually in different regions to confirm the implication of the study.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- TGY:
-
Triglycerides
- HDL-C:
-
High density lipoprotein-cholesterol
- LDL-Cz:
-
Low density lipoprotein-cholesterol
- TC:
-
Total cholesterol
- SBP:
-
Systolic blood pressure
- DBP:
-
Diastolic blood pressure
- FBG:
-
Fasting blood glucose
- BMI:
-
Body mass index
- WC:
-
Waist circumference
- SMD:
-
Standardized mean difference
- ORs:
-
Odds ratio
- CVD:
-
Cardiovascular disorder
References
Abuabara K, Lee H, Kimball AB (2011) The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study. Br J Dermatol 165:1066–1073. https://doi.org/10.1111/j.1365-2133.2011.10525.x
Aggarwal S, Nayek A, Pradhan D et al (2017) dbGAPs: A comprehensive database of genes and genetic markers associated with psoriasis and its subtypes. Genomics 110(4):240–247. https://doi.org/10.1016/j.ygeno.2017.10.003
Ahlehoff O, Skov L, Gislason G et al (2015) Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. J Eur Acad Dermatol Venereol 29:1128–1134. https://doi.org/10.1111/jdv.12768
Akcali C, Buyukcelik B, Kirtak N, Inaloz S (2014) Clinical and laboratory parameters associated with metabolic syndrome in Turkish patients with psoriasis. J Int Med Res 42:386–394. https://doi.org/10.1177/0300060513502891
Akhyani M, Ehsani AH, Robati RM, Robati AM (2007) The lipid profile in psoriasis: a controlled study. J Eur Acad Dermatol Venereol 21:1330–1332. https://doi.org/10.1111/j.1468-3083.2007.02260.x
Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M (2010) Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 37:146–155. https://doi.org/10.1111/j.1346-8138.2009.00777.x
Armesto S, Coto-Segura P, Osuna CG et al (2012) Psoriasis and hypertension: a case-control study. J Eur Acad Dermatol Venereol 26:785–788. https://doi.org/10.1111/j.1468-3083.2011.04108.x
Armstrong AW, Lin SW, Chambers CJ et al (2011) Psoriasis and hypertension severity: results from a case–control study. PLoS ONE 6:e18227. https://doi.org/10.1371/journal.pone.0018227
Armstrong AW, Harskamp CT, Armstrong EJ (2012) The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes 2:e54. https://doi.org/10.1038/nutd.2012.26
Baeta IGR, Bittencourt FV, Gontijo B, Goulart EMA (2014) Comorbidities and cardiovascular risk factors in patients with psoriasis. An Bras Dermatol 89:735–744. https://doi.org/10.1590/abd1806-4841.20142874
Balci A, Balci DD, Yonden Z et al (2010) Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome. Dermatology (Basel) 220:32–37. https://doi.org/10.1159/000254482
Barrea L, Macchia PE, Di Somma C et al (2016) Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome. J Transl Med 14:130. https://doi.org/10.1186/s12967-016-0889-6
Boehncke W-H, Boehncke S, Tobin A-M, Kirby B (2011) The “psoriatic march”: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 20:303–307. https://doi.org/10.1111/j.1600-0625.2011.01261.x
Chin Y-Y, Yu H-S, Li W-C et al (2013) Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study. J Eur Acad Dermatol Venereol 27:1262–1268. https://doi.org/10.1111/j.1468-3083.2012.04706.x
Choi WJ, Park EJ, Kwon IH et al (2010) Association between psoriasis and cardiovascular risk factors in Korean patients. Ann Dermatol 22:300–306. https://doi.org/10.5021/ad.2010.22.3.300
Coban M, Tasli L, Turgut S et al (2016) Association of adipokines, insulin resistance, hypertension and dyslipidemia in patients with psoriasis vulgaris. Ann Dermatol 28:74–79. https://doi.org/10.5021/ad.2016.28.1.74
Cohen AD, Weitzman D, Dreiher J (2010) Psoriasis and hypertension: a case-control study. Acta Derm Venereol 90:23–26. https://doi.org/10.2340/00015555-0741
Dreiher J, Weitzman D, Davidovici B et al (2008) Psoriasis and dyslipidaemia: a population-based study. Acta Derm Venereol 88:561–565. https://doi.org/10.2340/00015555-0510
Edson-Heredia E, Zhu B, Lefevre C et al (2015) Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using clinical practice research datalink. J Eur Acad Dermatol Venereol 29:955–963. https://doi.org/10.1111/jdv.12742
Farshchian M, Zamanian A, Farshchian M et al (2007) Serum lipid level in Iranian patients with psoriasis. J Eur Acad Dermatol Venereol 21:802–805. https://doi.org/10.1111/j.1468-3083.2006.02099.x
Farshchian M, Ansar A, Sobhan M (2015) Associations between cardiovascular risk factors and psoriasis in Iran. Clin Cosmet Investig Dermatol 8:437–442. https://doi.org/10.2147/CCID.S86418
Furue M, Tsuji G, Chiba T, Kadono T (2017) Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin. Intern Med 56:1613–1619. https://doi.org/10.2169/internalmedicine.56.8209
Ganguly S, Ray L, Kuruvila S et al (2018) Lipid accumulation product index as visceral obesity indicator in psoriasis: a case–control study. Indian J Dermatol 63:136–140. https://doi.org/10.4103/ijd.IJD_315_16
Gelfand JM (2016) Psoriasis, diabetes, and obesity: weighing the evidence. JAMA Dermatol 152:753–754. https://doi.org/10.1001/jamadermatol.2016.0670
Girisha BS, Thomas N (2017) Metabolic syndrome in psoriasis among urban south Indians: a case control study using SAM-NCEP criteria. J Clin Diagn Res 11:1–4. https://doi.org/10.7860/JCDR/2017/24717.9376
Gisondi P, Ferrazzi A, Girolomoni G (2010) Metabolic comorbidities and psoriasis. Acta Dermatovenerol Croat 18:297–304
Grossman RM, Delaney RJ, Brinton EA et al (1991) Hypertriglyceridemia in patients with psoriasis treated with cyclosporine. J Am Acad Dermatol 25:648–651. https://doi.org/10.1016/0190-9622(91)70247-y
Irimie M, Oanţă A, Irimie CA et al (2015) Cardiovascular risk factors in patients with chronic plaque psoriasis: a case-control study on the Brasov County population. Acta Dermatovenerol Croat 23:28–35
Karbach S, Croxford AL, Oelze M et al (2014) Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol 34:2658–2668. https://doi.org/10.1161/ATVBAHA.114.304108
Karoli R, Fatima J, Shukla V et al (2013) A study of cardio-metabolic risk profile in patients with psoriasis. J Assoc Physicians India 61:798–803
Katz HI, Waalen J, Leach EE (1999) Acitretin in psoriasis: an overview of adverse effects. J Am Acad Dermatol 41:S7–S12. https://doi.org/10.1016/s0190-9622(99)70359-2
Khalid U, Hansen PR, Gislason GH et al (2013) Psoriasis and new-onset diabetes: a Danish nationwide cohort study. Diabetes Care 36:2402–2407. https://doi.org/10.2337/dc12-2330
Kim WB, Jerome D, Yeung J (2017) Diagnosis and management of psoriasis. Can Fam Physician 63:278–285
Kothiwala SK, Khanna N, Tandon N et al (2016) Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study. Indian J Dermatol Venereol Leprol 82:510–518. https://doi.org/10.4103/0378-6323.183638
Kumar S, Han J, Li T et al (2013) Obesity, waist circumference, weight change, and the risk of psoriasis in US women. J Eur Acad Dermatol Venereol 27:1293–1298. https://doi.org/10.1111/jdv.12001
Lan C-CE, Ko Y-C, Yu H-S et al (2012) Methotrexate reduces the occurrence of cerebrovascular events among Taiwanese psoriatic patients: a nationwide population-based study. Acta Derm Venereol 92:349–352. https://doi.org/10.2340/00015555-1283
Langan SM, Seminara NM, Shin DB et al (2012) Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 132:556–562. https://doi.org/10.1038/jid.2011.365
Lee M-S, Lin R-Y, Lai M-S (2014) Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. J Am Acad Dermatol 70:691–698. https://doi.org/10.1016/j.jaad.2013.11.023
Love TJ, Qureshi AA, Karlson EW et al (2011) Prevalence of the metabolic syndrome in psoriasis: results from the national health and nutrition examination survey, 2003–2006. Arch Dermatol 147:419–424. https://doi.org/10.1001/archdermatol.2010.370
Lu Y, Chen H, Nikamo P et al (2013) Association of cardiovascular and metabolic disease genes with psoriasis. J Invest Dermatol 133:836–839. https://doi.org/10.1038/jid.2012.366
Ma L, Li M, Wang H et al (2014) High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China. Arch Dermatol Res 306:247–251. https://doi.org/10.1007/s00403-013-1437-3
Mallbris L, Akre O, Granath F et al (2004) Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 19:225–230. https://doi.org/10.1023/b:ejep.0000020447.59150.f9
Masson Regnault M, Konstantinou M-P, Khemis A et al (2017) Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients. J Eur Acad Dermatol Venereol 31:1491–1496. https://doi.org/10.1111/jdv.14387
Mehta NN, Azfar RS, Shin DB et al (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database. Eur Heart J 31:1000–1006. https://doi.org/10.1093/eurheartj/ehp567
Milčić D, Janković S, Vesić S et al (2017) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study. An Bras Dermatol 92:46–51. https://doi.org/10.1590/abd1806-4841.20175178
Miller IM, Ellervik C, Yazdanyar S, Jemec GBE (2013) Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol 69:1014–1024. https://doi.org/10.1016/j.jaad.2013.06.053
Owczarczyk-Saczonek A, Placek W (2017) Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders. Int J Dermatol 56:260–268. https://doi.org/10.1111/ijd.13420
Parodi A, Aste N, Calvieri C et al (2014) Metabolic syndrome prevalence in psoriasis: a cross-sectional study in the Italian population. Am J Clin Dermatol 15:371–377. https://doi.org/10.1007/s40257-014-0074-8
Pehlevan S, Yetkin DO, Bahadır C et al (2014) Increased prevalence of metabolic syndrome in patients with psoriatic arthritis. Metab Syndr Relat Disord 12:43–48. https://doi.org/10.1089/met.2013.0039
Piskin S, Gurkok F, Ekuklu G, Senol M (2003) Serum lipid levels in psoriasis. Yonsei Med J 44:24–26. https://doi.org/10.3349/ymj.2003.44.1.24
Praveenkumar U, Ganguly S, Ray L et al (2016) Prevalence of metabolic syndrome in psoriasis patients and its relation to disease duration: a hospital based case-control study. J Clin Diagn Res 10:1–5. https://doi.org/10.7860/JCDR/2016/17791.7218
Prodanovich S, Kirsner RS, Kravetz JD et al (2009) Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 145:700–703. https://doi.org/10.1001/archdermatol.2009.94
Raimondo A, Balato A, Megna M, Balato N (2018) Limitations of current monoclonal antibodies for plaque-type psoriasis and an outlook for the future. Expert Opin Biol Ther 18:605–607. https://doi.org/10.1080/14712598.2018.1479738
Ražnatović-Đurović M, Janković J, Janković S (2016) Prevalence of metabolic syndrome in Montenegrin patients with psoriasis. Vojnosanit Pregl 73:1016–1021. https://doi.org/10.2298/VSP150114138R
Richard M-A, Barnetche T, Horreau C et al (2013) Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion. J Eur Acad Dermatol Venereol 27(Suppl 3):2–11. https://doi.org/10.1111/jdv.12162
Schiattarella M, Caiazzo G, Di Caprio R, et al (2019) Paraoxonases and psoriasis: negative imbalance of antioxidant endogenous mechanisms. Ital Dermatol Venereol 154:192–196. https://doi.org/10.23736/S0392-0488.17.05537-7
Setty AR, Curhan G, Choi HK (2007) Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses’ Health Study II. Arch Intern Med 167:1670–1675. https://doi.org/10.1001/archinte.167.15.1670
Shah K, Mellars L, Changolkar A, Feldman SR (2017) Real-world burden of comorbidities in US patients with psoriasis. J Am Acad Dermatol 77:287–292.e4. https://doi.org/10.1016/j.jaad.2017.03.037
Sharma YK, Prakash N, Gupta A (2016) Prevalence of metabolic syndrome as per the NCEP and IDF definitions vis-a-vis severity and duration of psoriasis in a semi-urban Maharashtrian population: a case control study. Diabetes Metab Syndr 10:S72–76. https://doi.org/10.1016/j.dsx.2016.01.033
Siegel D, Devaraj S, Mitra A et al (2013) Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol 44:194–204. https://doi.org/10.1007/s12016-012-8308-0
Singh S, Dogra S, Shafiq N et al (2017) Prevalence of metabolic syndrome in psoriasis and levels of interleukin-6 and tumor necrosis factor-α in psoriasis patients with metabolic syndrome: Indian tertiary care hospital study. Int J Appl Basic Med Res 7:169–175. https://doi.org/10.4103/ijabmr.IJABMR_330_16
Singh S, Pradhan D, Puri P et al (2019) Genomic alterations driving psoriasis pathogenesis. Gene 683:61–71. https://doi.org/10.1016/j.gene.2018.09.042
Sommer DM, Jenisch S, Suchan M et al (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298:321–328. https://doi.org/10.1007/s00403-006-0703-z
Tablazon ILD, Al-Dabagh A, Davis SA, Feldman SR (2013) Risk of cardiovascular disorders in psoriasis patients: current and future. Am J Clin Dermatol 14:1–7. https://doi.org/10.1007/s40257-012-0005-5
Taheri SM, Hedayati MT, Shokohi T, HajHeydari Z (2014) Serum lipids and lipoproteins in patients with psoriasis. Arch Iran Med 17:343–346. https://doi.org/0141705/AIM.007
Takeshita J, Grewal S, Langan SM et al (2017) Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol 76:377–390. https://doi.org/10.1016/j.jaad.2016.07.064
Toker A, Kadi M, Yildirim AK et al (2009) Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 27:176–180. https://doi.org/10.1002/cbf.1553
Uczniak S, Gerlicz ZA, Kozłowska M, Kaszuba A (2016) Presence of selected metabolic syndrome components in patients with psoriasis vulgaris. Postepy Dermatol Alergol 33:114–119. https://doi.org/10.5114/ada.2016.59153
Uyanik BS, Ari Z, Onur E et al (2002) Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med 40:65–68. https://doi.org/10.1515/CCLM.2002.013
Vayá A, Ricart JM, Andino B et al (2013) Psoriasis and hemorheology: influence of the metabolic syndrome. Clin Hemorheol Microcirc 55:331–339. https://doi.org/10.3233/CH-2012-1639
Zindancı I, Albayrak O, Kavala M et al (2012) Prevalence of metabolic syndrome in patients with psoriasis. Sci World J 2012:312463. https://doi.org/10.1100/2012/312463
Acknowledgement
The authors acknowledge the University Grant Commission, India, for providing doctoral fellowship to Ms. Saumya Choudhary (Grant Number: .2014-15-MANF-2014-15-MUS-UTT-39790).
Author information
Authors and Affiliations
Contributions
Saumya Choudhary, Rachna Patel, Dibyabhaba Pradhan: acquisition of data. Saumya Choudhary, Rachna Patel, Dibyabhaba Pradhan: analysis or interpretation of data. All authors: concept or design, drafting of the manuscript and critical revision.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare there are no competing interests.
Ethical approval
The present meta-analysis is exempted from ethical approval, as data were obtained from previous studies in which informed consent was already obtained by the trial investigator, and the present analysis will be addressing similar questions to the research question for which the data were collected.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Choudhary, S., Patel, R., Pradhan, D. et al. Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies. 3 Biotech 10, 104 (2020). https://doi.org/10.1007/s13205-020-2089-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-020-2089-6